NATCO Pharma Limited (BOM:524816)
India · Delayed Price · Currency is INR 813.20
-5.80 (-0.71%)
At close: Sep 16, 2026
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 146.72 billion as of September 16, 2026. Its market cap has decreased by -3.79% in one year.
Market Cap
146.72B
Enterprise Value
132.57B
Revenue
34.85B
Ranking
n/a
PE Ratio
12.82
Stock Price
813.20
ChartMarket Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 146.72B, an increase of 34,069.02%. That is a compound annual growth rate of 23.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 146.72B | -9.29% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 216.20B |
| Caplin Point Laboratories | 195.41B |
| AstraZeneca Pharma India | 167.33B |
| Jubilant Pharmova | 159.91B |
| Viyash Scientific | 107.87B |
| Procter & Gamble Health | 90.04B |
| Bliss GVS Pharma | 72.94B |